Concepedia

John J. Ko

JJ

Statistics

Publications

15

Citations

1.4K

H-Index

14

Active since

2000

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Novartis (United States)

King's College Hospital

The University of Texas Medical Branch at Galveston

University of Modena and Reggio Emilia

John J. Ko is an author at Alnylam Pharmaceuticals (United States) specializing in pharmacy, liver disease, and medicine.

ORCID

Publications per year

2000–2022

15

Publications

15

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

Manisha Balwani, Eliane Sardh, Paolo Ventura et al. · New England Journal of Medicine · 2020 · 592 citations · Full text

, , +14

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

Laurent Gouya, Paolo Ventura, Manisha Balwani et al. · Hepatology · 2019 · 171 citations · Full text

, , +11

Increasing Patient Involvement in Drug Development

Maria Lowe, David A. Blaser, Lisa Cone et al. · Value in Health · 2016 · 115 citations · Full text

, , +7

Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year

Kristen Johnson, Huanxue Zhou, Feng Lin et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 79 citations · Full text

, , +15

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study

P. Ventura, Herbert L. Bonkovsky, Laurent Gouya et al. · Liver International · 2021 · 77 citations · Full text

, , +14

1–5 of 15